• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与阻力储备率受损和微血管阻力储备相关的因素。

Factors Associated with Impaired Resistive Reserve Ratio and Microvascular Resistance Reserve.

作者信息

Yamazaki Tatsuro, Saito Yuichi, Yamashita Daichi, Kitahara Hideki, Kobayashi Yoshio

机构信息

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.

出版信息

Diagnostics (Basel). 2023 Mar 2;13(5):950. doi: 10.3390/diagnostics13050950.

DOI:10.3390/diagnostics13050950
PMID:36900097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10000988/
Abstract

Coronary microvascular dysfunction (CMD) is described as an important subset of ischemia with no obstructive coronary artery disease. Resistive reserve ratio (RRR) and microvascular resistance reserve (MRR) have been proposed as novel physiological indices evaluating coronary microvascular dilation function. The aim of this study was to explore factors associated with impaired RRR and MRR. Coronary physiological indices were invasively evaluated in the left anterior descending coronary artery using the thermodilution method in patients suspected of CMD. CMD was defined as a coronary flow reserve <2.0 and/or index of microcirculatory resistance ≥25. Of 117 patients, 26 (24.1%) had CMD. RRR (3.1 ± 1.9 vs. 6.2 ± 3.2, < 0.001) and MRR (3.4 ± 1.9 vs. 6.9 ± 3.5, < 0.001) were lower in the CMD group. In the receiver operating characteristic curve analysis, RRR (area under the curve 0.84, < 0.001) and MRR (area under the curve 0.85, < 0.001) were both predictive of the presence of CMD. In the multivariable analysis, previous myocardial infarction, lower hemoglobin, higher brain natriuretic peptide levels, and intracoronary nicorandil were identified as factors associated with lower RRR and MRR. In conclusion, the presence of previous myocardial infarction, anemia, and heart failure was associated with impaired coronary microvascular dilation function. RRR and MRR may be useful to identify patients with CMD.

摘要

冠状动脉微血管功能障碍(CMD)被描述为无阻塞性冠状动脉疾病的缺血的一个重要子集。阻力储备率(RRR)和微血管阻力储备(MRR)已被提出作为评估冠状动脉微血管舒张功能的新的生理指标。本研究的目的是探讨与RRR和MRR受损相关的因素。在疑似CMD的患者中,使用热稀释法对左前降支冠状动脉进行有创性冠状动脉生理指标评估。CMD被定义为冠状动脉血流储备<2.0和/或微循环阻力指数≥25。在117例患者中,26例(24.1%)患有CMD。CMD组的RRR(3.1±1.9对6.2±3.2,<0.001)和MRR(3.4±1.9对6.9±3.5,<0.001)较低。在受试者工作特征曲线分析中,RRR(曲线下面积0.84,<0.001)和MRR(曲线下面积0.85,<0.001)均能预测CMD的存在。在多变量分析中,既往心肌梗死、较低的血红蛋白、较高的脑钠肽水平和冠状动脉内尼可地尔被确定为与较低的RRR和MRR相关的因素。总之,既往心肌梗死、贫血和心力衰竭的存在与冠状动脉微血管舒张功能受损有关。RRR和MRR可能有助于识别CMD患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/eb5c8f6ebc02/diagnostics-13-00950-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/95ab52225f34/diagnostics-13-00950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/529768c4cbdf/diagnostics-13-00950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/0490eaed14c6/diagnostics-13-00950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/5a49e6e6fe47/diagnostics-13-00950-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/9c6d93ce8c9e/diagnostics-13-00950-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/42942a190029/diagnostics-13-00950-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/eb5c8f6ebc02/diagnostics-13-00950-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/95ab52225f34/diagnostics-13-00950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/529768c4cbdf/diagnostics-13-00950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/0490eaed14c6/diagnostics-13-00950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/5a49e6e6fe47/diagnostics-13-00950-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/9c6d93ce8c9e/diagnostics-13-00950-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/42942a190029/diagnostics-13-00950-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7fe/10000988/eb5c8f6ebc02/diagnostics-13-00950-g007.jpg

相似文献

1
Factors Associated with Impaired Resistive Reserve Ratio and Microvascular Resistance Reserve.与阻力储备率受损和微血管阻力储备相关的因素。
Diagnostics (Basel). 2023 Mar 2;13(5):950. doi: 10.3390/diagnostics13050950.
2
Prognostic Implications of Microvascular Resistance Reserve in Symptomatic Patients With Intermediate Coronary Stenosis.症状性中度冠状动脉狭窄患者微血管阻力储备的预后意义。
JACC Cardiovasc Interv. 2024 Mar 25;17(6):786-797. doi: 10.1016/j.jcin.2024.01.008.
3
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve.2型糖尿病患者的微血管功能障碍:绝对冠状动脉血流和微血管阻力储备的有创评估
Front Cardiovasc Med. 2021 Oct 19;8:765071. doi: 10.3389/fcvm.2021.765071. eCollection 2021.
4
Microvascular Resistance Reserve to Assess Microvascular Dysfunction in ANOCA Patients.评估非心源性心源性昏迷患者微血管功能障碍的微血管阻力储备。
JACC Cardiovasc Interv. 2023 Feb 27;16(4):470-481. doi: 10.1016/j.jcin.2022.12.012.
5
Coronary microvascular dysfunction in Takotsubo syndrome and associations with left ventricular function.应激性心肌病的冠状动脉微血管功能障碍及其与左心室功能的关系。
ESC Heart Fail. 2023 Aug;10(4):2395-2405. doi: 10.1002/ehf2.14394. Epub 2023 May 22.
6
Resistive reserve ratio and microvascular resistance reserve in patients with coronary vasospastic angina.冠状动脉痉挛性心绞痛患者的阻力储备比和微血管阻力储备。
Heart Vessels. 2022 Sep;37(9):1489-1495. doi: 10.1007/s00380-022-02051-w. Epub 2022 Mar 17.
7
Incremental Value of Coronary Microcirculation Resistive Reserve Ratio in Predicting the Extent of Myocardial Infarction in Patients with STEMI. Insights from the Oxford Acute Myocardial Infarction (OxAMI) Study.冠状动脉微循环阻力储备比值在预测ST段抬高型心肌梗死患者心肌梗死范围中的增量价值。来自牛津急性心肌梗死(OxAMI)研究的见解。
Cardiovasc Revasc Med. 2019 Dec;20(12):1148-1155. doi: 10.1016/j.carrev.2019.01.022. Epub 2019 Feb 16.
8
Continuous thermodilution and microvascular resistance reserve during the index procedure in acute coronary syndrome without obstructive coronary artery disease: A pilot study.急性非阻塞性冠状动脉综合征指数操作过程中的持续热稀释法和微血管阻力储备:一项初步研究。
Catheter Cardiovasc Interv. 2024 Aug;104(2):241-246. doi: 10.1002/ccd.31122. Epub 2024 Jun 19.
9
Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.心力衰竭患者的冠状动脉微血管功能障碍:HFrEF 与 HFpEF 患者的特征模式。
Circ Heart Fail. 2024 Jan;17(1):e010805. doi: 10.1161/CIRCHEARTFAILURE.123.010805. Epub 2023 Dec 18.
10
Reproducibility of bolus versus continuous thermodilution for assessment of coronary microvascular function in patients with ANOCA.对比球囊扩张与连续热稀释法评估非阻塞性冠状动脉疾病患者冠状动脉微血管功能的重复性。
EuroIntervention. 2023 Jun 5;19(2):e155-e166. doi: 10.4244/EIJ-D-22-00772.

引用本文的文献

1
Factors Contributing to Coronary Microvascular Dysfunction in Patients with Angina and Non-Obstructive Coronary Artery Disease.心绞痛和非阻塞性冠状动脉疾病患者冠状动脉微血管功能障碍的相关因素
J Cardiovasc Dev Dis. 2024 Jul 10;11(7):217. doi: 10.3390/jcdd11070217.
2
Thrombolysis in Myocardial Infarction Frame Count for Coronary Blood Flow Evaluation during Interventional Diagnostic Procedures.心肌梗死溶栓帧数用于介入诊断程序中冠状动脉血流评估。
Medicina (Kaunas). 2023 Dec 15;59(12):2185. doi: 10.3390/medicina59122185.
3
Feeling connected to nature: validation of the connectedness to nature scale in the Italian context.

本文引用的文献

1
The Dynamic Relationship Between Invasive Microvascular Function and Microvascular Injury Indicators, and Their Association With Left Ventricular Function and Infarct Size at 1-Month After Reperfused ST-Segment-Elevation Myocardial Infarction.再灌注性ST段抬高型心肌梗死后1个月时,有创微血管功能与微血管损伤指标之间的动态关系及其与左心室功能和梗死面积的关联
Circ Cardiovasc Interv. 2022 Nov;15(11):892-902. doi: 10.1161/CIRCINTERVENTIONS.122.012081. Epub 2022 Oct 28.
2
Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese association of cardiovascular intervention and therapeutics-update 2022.压力导丝生理性病变评估的临床应用:日本心血管介入治疗协会专家共识文件更新 2022 版。
Cardiovasc Interv Ther. 2022 Jul;37(3):425-439. doi: 10.1007/s12928-022-00863-1. Epub 2022 May 11.
3
与自然的联结感:意大利背景下自然联结量表的效度验证
Front Psychol. 2023 Oct 12;14:1242699. doi: 10.3389/fpsyg.2023.1242699. eCollection 2023.
Resistive reserve ratio and microvascular resistance reserve in patients with coronary vasospastic angina.冠状动脉痉挛性心绞痛患者的阻力储备比和微血管阻力储备。
Heart Vessels. 2022 Sep;37(9):1489-1495. doi: 10.1007/s00380-022-02051-w. Epub 2022 Mar 17.
4
Discrepancy between plaque vulnerability and functional severity of angiographically intermediate coronary artery lesions.血管造影中间型冠状动脉病变斑块易损性与功能严重程度的差异。
Cardiovasc Interv Ther. 2022 Oct;37(4):691-698. doi: 10.1007/s12928-022-00851-5. Epub 2022 Mar 8.
5
Coronary blood flow in heart failure: cause, consequence and bystander.心力衰竭中的冠状动脉血流:原因、后果和旁观者。
Basic Res Cardiol. 2022 Jan 13;117(1):1. doi: 10.1007/s00395-022-00909-8.
6
Management of ischaemia with non-obstructive coronary arteries (INOCA).非阻塞性冠状动脉疾病(INOCA)所致缺血的管理。
BMJ. 2021 Nov 26;375:e060602. doi: 10.1136/bmj-2021-060602.
7
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve.2型糖尿病患者的微血管功能障碍:绝对冠状动脉血流和微血管阻力储备的有创评估
Front Cardiovasc Med. 2021 Oct 19;8:765071. doi: 10.3389/fcvm.2021.765071. eCollection 2021.
8
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估与诊断指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Nov 30;144(22):e368-e454. doi: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28.
9
Microvascular Resistance Reserve for Assessment of Coronary Microvascular Function: JACC Technology Corner.微血管阻力储备评估冠状动脉微血管功能:JACC 技术角。
J Am Coll Cardiol. 2021 Oct 12;78(15):1541-1549. doi: 10.1016/j.jacc.2021.08.017.
10
Risk Stratification of Patients With NonObstructive Coronary Artery Disease Using Resistive Reserve Ratio.应用阻力储备比值对非阻塞性冠状动脉疾病患者进行风险分层。
J Am Heart Assoc. 2021 Jun;10(11):e020464. doi: 10.1161/JAHA.120.020464. Epub 2021 May 15.